Brain oxygenation may be compromised during periodic discharges, ultimately warranting treatment.
Nearly 60% of patients had achieved seizure freedom at last follow-up, 10 to 21 years after surgery.
Careful monitoring of EEG patterns is a useful way to stratify seizure risk in critically ill patients.
The results confirm the effectiveness and safety of low-dose CBZ as a first-line agent for the treatment of neonatal seizures.
Greater spasm cessation was achieved in the combination group vs those who received hormonal therapy alone.
Beate Diehl, MD, PhD, FRCP, discusses her research on post-stroke epilepsy.
Shaun Hussain, MD, MS, discusses a gap in health care provider knowledge that may contribute to the delay in the diagnosis and treatment of infantile spasms.
Elizabeth Thiele, MD, PhD discusses results from her research on cannabidiol in Lennox-Gastaut syndrome.
Clobazam had been previously identified as an AED with a significant interaction with CBD.
Justin Gover, CEO of GW Pharmaceuticals, the parent company of Greenwich Biosciences, discusses the status of the company's cannabidiol product Epidiolex on the heels of positive results from several placebo-controlled trials in epileptic syndromes.
Number of AEDs and seizure frequency also influenced depression in people with epilepsy.
Concordant EEG/fMRI and ESI predicted outcomes with 100% sensitivity and specificity.
Adjunctive everolimus treatment has been found to significantly reduce frequency of treatment-resistant seizures in TSC.
The triple-validated SeLECT score may help identify patients suited for antiepileptic drug trials.
Results of the phase 3, placebo-controlled trial support previous findings from an expanded-access program.
Brain Atrophy May Help Predict Surgical Outcomes in Mesial Temporal Lobe Epilepsy With Hippocampal SclerosisDecember 04, 2016
Atrophy in areas outside of the MTLE-HS network may predict poor surgical outcomes.
Less than 30% of patients were seen by an effective provider within 1 week of onset of infantile spasms.
Half of patients experienced a reduction in seizure frequency after statin initiation.
Awareness of the effects of polypharmacy on patient well-being is an important component of care.
Patients taking cannabidiol experienced a significant reduction in drop seizures compared with placebo.
Patients with lesions in the left basal ganglia were more likely to have post-stroke epilepsy.
Michael Privatera, MD, AES president spoke with Neurology Advisor about some of the key topics and presentations slated for this year's meeting.
Veterans with epilepsy could benefit from evidence-based chronic disease self-management programs that target physical and psychiatric comorbidities.
Lack of adherence has been linked to increased risks of intubation and ICU admission.
Data suggests that epileptogenic mechanisms may be triggered by changes in the intrauterine environment during pregnancy in women with RA.
Those with older age at seizure onset are at the greatest risk for decline in naming ability.
Dr Elizabeth Thiele discusses the latest on cannabidiol research for the treatment of refractory epilepsy.
Patients with these EEG characteristics may benefit from early screening and intervention.
The EXIST-3 trial is the first phase 3 study to evaluate the use of EVE for the adjunctive treatment of seizures in TSC.
Those suffering from depression and those diagnosed with temporal lobe epilepsy present with dysfunction across several cognitive domains.
Neurology Advisor Articles
- Migraine Relief After Chiropractic Manipulation Likely a Placebo Effect
- No Benefit for IV tPA Before Mechanical Thrombectomy in Ischemic Stroke
- Vitamin D Levels Linked to Migraine in Men
- Template Improves Quality of Report on MRI for Multiple Sclerosis
- Should EEG Periodic Discharges be Managed Similarly to Seizures?